Visit our Grünenthal Medical Team at the EFIC conference!

Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a 75 years history of bringing innovative treatments and state-of-the-art technologies to patients worldwide.

Our purpose is to change lives for the better, and innovation is our passion. We are focusing all our activities and efforts on working towards our vision of a world free of pain.

Meet the medical colleagues from Grünenthal at the EFIC conference 2023 in Budapest!

You can find our booth at the entrance of the exhibition hall.

Our Vision: A World Free of Pain

Our Grünenthal commitment to support pain research!

EFIC-Grünenthal Grant

With a total value of €100,000, this biennial grant rewards innovative projects for human pain research and supports promising early-career researchers. Since its start in 2004, 73 EFIC-Grünenthal Grant projects (693 applications) have been supported.

Join the EFIC 2023 opening ceremony on September 20 at 18:30 when EFIC and Grünenthal will announce the three recipients of the 2023 EFIC-Grünenthal Grant (E-G-G)!

Main theme of the medical activities at EFIC 2023 is about NEUROPATHIC PAIN. Worldwide up to 10% of people are living with neuropathic pain* as a complication or consequence of several diseases and their treatments like painful diabetic peripheral neuropathies or cancer related neuropathic pain. Neuropathic pain can have a significant impact on the people who are affected and their families.

Download the infographics with the results from two web based surveys where people living with diabetes** and cancer*** reported from their experiences living with neuropathic pain.

Change Pain infographic - Burden of diabetes
Change Pain infographic - Burden of cancer

* Van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014 Apr;155(4):654-662

** Tesfaye S, Brill S, Eerdekens M, Maderuelo Labrador M, Petersen G, de Rooij Peek A, Reta A, Ryan D, Schaper N, Tölle T, Truini A, Ziegler D. Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries. Journal of Diabetes and its Complications. 2023 Apr; 37(4): 108417.

***Dupoiron D, Brill S, Eeltink C, Barragán B, Bell D, Petersen G, Eerdekens M, Ryan D, Rakuša M. Diagnosis, management and impact on patients’ lives of cancer-related neuropathic pain (CRNP): A European survey. European journal of Cancer Care. 2022 Nov; 31(6): e13728.

Join the EFIC poster session on September 22 (12:30 – 13:30) where Silviu Brill will present the results from the pDPN patient survey “Diagnosis and treatment of painful diabetic neuropathy: comparison of patient experiences in four European countries” (Poster 60).

Listen to the patient voice!

Watch the interview with Angela de Rooj from the Dutch Diabetes Patient Association about the experiences from people living with diabetic neuropathic pain.

Striking a nerve: Attend the Grünenthal lunch symposium on Thursday 21 September!

Prof. Gisèle Pickering (University Hospital of Clermont-Ferrand, France) and Prof. Rainer Freynhagen (Benedictus Krankenhaus Tutzing, Germany) who are experts in this field will share their experiences in this session which is moderated by Lloyd Bracey and is taking place on 21 September from 12:30 – 13:30 in the room Parallel 2.

Meet a clinical expert to learn more about the management of neuropathic pain!

During the EFIC conference from September 20-22 you have the chance to book 15 min time slots to meet the following experts:

  • Dr. Denis Dupoiron (Institut de Cancérologie de l‘Ouest, Angers, France)
  • Prof. Ralf Baron (Albrechts-Universität Kiel, Germany)

Ask the Grünenthal medical team for available slots to meet the experts at our medical booth!

Visit our medical booth to learn more about the impact and management of neuropathic pain!

You want to learn more about neuropathic pain?

Register to the NeuPSIG CME credited modules from September 2023 which have been sponsored by Grünenthal.

  1. Painful diabetic neuropathy module
    The session focuses on the diagnosis of and treatment options for pDPN, and the management of the pain. Diabetic neuropathy is a serious diabetes complication that affects many people with diabetes.
  2. Cancer pain module
    The session focuses on cancer pain across the cancer cycle from diagnosis, pre, post-surgical and chemotherapy states, and the encompassing management of pain. Cancer pain has been identified as having significant prevalence across the globe.

Please contact us at if you wish more information or connect with the local Grünenthal teams here!